{
Jonathan Gardner

People

}
001122334455554433221100
001122334455554433221100

AstraZeneca and Daiichi Sankyo Advance Cancer Drug Amid Industry Developments

AstraZeneca and Daiichi Sankyo announced new study results for their cancer drug datopotamab deruxtecan, showing a median survival of 15.6 months in patients with EGFR-mutated non-small cell lung cancer. Agenus plans to cut annual spending by 60% to focus on a late-stage cancer immunotherapy, while Amgen is investing $1 billion to expand its manufacturing in North Carolina. The U.S. Patent and Trademark Office has withdrawn a proposed rule aimed at reducing patent thickets, and Bluebird bio is executing a reverse stock split to comply with Nasdaq rules. Merus received FDA accelerated approval for zenocutuzumab, its first approved product.
BioPharma Dive
bluebird bio, Inc. AstraZeneca PLC Daiichi Sankyo Co Ltd Amgen Inc. Merus N.V. Delilah Alvarado Ned Pagliarulo Jonathan Gardner Ben Fidler Show more
Healthcare, News Article
01:00 06.12.2024

gsk invests 800 million in us manufacturing amgen launches eylea biosimilar

GSK is investing $800 million to expand its manufacturing site in Marietta, Pennsylvania, focusing on sterile liquid vaccines and drug substances, with operations expected by 2027 and 2028. Amgen has set a list price of $1,665 for its Eylea biosimilar, Pavblu, launching without a legal settlement, which may lead to penalties if future rulings favor Regeneron. Meanwhile, Roche has partnered with Dyno Therapeutics for gene therapy advancements, and AbbVie is collaborating with Gideon Richter on neuropsychiatric treatments. Marinus Pharmaceuticals is laying off staff after its seizure drug ganaxolone failed to meet Phase 3 study goals.
BioPharma Dive
United States Dollar Hoffmann-La Roche AG AbbVie Inc. Amgen Inc. Glaxosmithkline Export Ltd. Marinus Pharmaceuticals, Inc. USA Ned Pagliarulo Brian Abrahams Jonathan Gardner Jacob Bell Show more
Healthcare, Market Report
16:35 25.10.2024

merck acquires cancer startup elevidys sales rise and other industry updates

Merck & Co. has acquired Modifi Biosciences for $30 million, with potential additional payments of up to $1.3 billion based on milestones. Meanwhile, Roche reported that sales of Sarepta's gene therapy Elevidys reached approximately $156 million outside the U.S. in the first nine months of the year. Sangamo Therapeutics is on track to file for accelerated approval of its Fabry disease treatment, while MacroGenics sold rights to its breast cancer drug Margenza for $40 million, with additional milestone payments possible.
BioPharma Dive
United States Dollar Swiss Franc Hoffmann-La Roche AG Merck & Co., Inc. UCB SA Sarepta Therapeutics, Inc. Sangamo Therapeutics, Inc. Ned Pagliarulo Delilah Alvarado Jonathan Gardner Alessandro Maselli Show more
Healthcare, Market Report
17:45 23.10.2024

nobel prize awarded for protein design and drug developments advance

David Baker, Demis Hassabis, and John Jumper have won the Nobel Prize in Chemistry for their groundbreaking work in computational protein design and structure prediction, significantly advancing drug design capabilities. Alnylam Pharmaceuticals seeks FDA approval for vutrisiran to treat a severe form of transthyretin amyloidosis, while Johnson & Johnson halts a bladder cancer trial for TAR-200. AstraZeneca invests in a preclinical cholesterol-lowering drug, and Astellas acquires rights to an experimental gene therapy for frontotemporal dementia.
BioPharma Dive
United States Dollar Eli Lilly and Company AviadoBio Alnylam Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. Amgen Inc. Astellas Pharma Inc. Pfizer Inc. BridgeBio Pharma, Inc. Novartis AG AstraZeneca PLC Johnson & Johnson USA SWE JPN BRA HKG John Jumper David Baker Jonathan Gardner Demis Hassabis Jim Wilson Show more
Healthcare, News Article
13:00 09.10.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Global Trade Developments Global Financial Events Banking Regulations Central Bank Actions Retail and Consumer Goods Finance Mergers & Acquisitions Startups & Entrepreneurship Inflation and Monetary Impact Industry Mergers & Acquisitions Government Economic Policies CEO Changes Domestic Politics Market Analysis and Predictions Workplace Trends Government Policies Supply Chain Management GDP Growth & Recession Forecasts
Countries:
USA CHN GBR CHE DEU IND FRA JPN CAN VNM AUS MEX ITA ARE SGP THA ESP MYS TWN NLD
Companies:
Tesla, Inc. Apple Inc. Barclays PLC JPMorgan Chase & Co. Deutsche Bank Money Market PP Credit Suisse Strategic Income I The Goldman Sachs Group, Inc. Berkshire Hathaway Inc. UBS Group AG BNP Paribas SA Banco Santander, S.A. Lloyds Banking Group plc SpaceXCoin USD Bank of America Corporation NVIDIA Corporation Jenoptik AG Air France-KLM Amazon.com, Inc. Wells Fargo & Company Infineon Technologies AG
Currencies:
United States Dollar Euro British Pound Sterling Swiss Franc Japanese Yen Indian Rupee Chinese Yuan Canadian Dollar Vietnamese Đồng South Korean Won Australian Dollar Thai Baht Indonesian Rupiah Singapore Dollar Mexican Peso Hong Kong Dollar Offshore Chinese Yuan New Zealand Dollar Cambodian Riel Myanmar Kyat
People:
Donald Trump Elon Musk JD Vance Sergio Ermotti Warren Buffett Mark Haefele Jennifer Piepszak Ursula von der Leyen Olivier Calvet Scott Bessent Karoline Leavitt George Saravelos Francois Xavier Bouvignies Joseph Spak Robin Leopold Susan P. Crawford Greg Rubini Dan Ives Narendra Modi Joe Biden

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.